Works matching DE "DAUNOMYCIN"


Results: 422
    1
    2
    3
    4
    5

    Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia.

    Published in:
    JAMA Network Open, 2024, v. 7, n. 5, p. e2411726, doi. 10.1001/jamanetworkopen.2024.11726
    By:
    • Lamba, Jatinder K.;
    • Marrero, Richard;
    • Wu, Huiyun;
    • Cao, Xueyuan;
    • Parcha, Phani Krisha;
    • Karol, Seth E.;
    • Inaba, Hiroto;
    • Kuo, Dennis John;
    • Degar, Barbara A.;
    • Heym, Kenneth;
    • Taub, Jeffrey W.;
    • Lacayo, Norman J.;
    • Pui, Ching-Hon;
    • Ribeiro, Raul C.;
    • Pounds, Stanley B.;
    • Rubnitz, Jeffrey E.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Design of New Daunorubicin Derivatives with High Cytotoxic Potential.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 3, p. 1270, doi. 10.3390/ijms26031270
    By:
    • Kalashnikova, Aleksandra A.;
    • Toibazarova, Altynkul B.;
    • Artyushin, Oleg I.;
    • Anikina, Lada V.;
    • Globa, Anastasiya A.;
    • Klemenkova, Zinaida S.;
    • Andreev, Maxim V.;
    • Radchenko, Eugene V.;
    • Palyulin, Vladimir A.;
    • Aleksandrova, Yulia R.;
    • Syzdykbayev, Marat I.;
    • Appazov, Nurbol O.;
    • Chubarev, Vladimir N.;
    • Neganova, Margarita E.;
    • Brel, Valery K.
    Publication type:
    Article
    30
    31

    A Stereochemically Driven Supramolecular Polymerisation.

    Published in:
    Chemistry - A European Journal, 2018, v. 24, n. 32, p. 8195, doi. 10.1002/chem.201800644
    By:
    • Tasca, Elisamaria;
    • D'abramo, Marco;
    • Galantini, Luciano;
    • Giuliani, Anna Maria;
    • Pavel, Nicolae Viorel;
    • Palazzo, Gerardo;
    • Giustini, Mauro
    Publication type:
    Article
    32
    33
    34
    35
    36
    37

    Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1094, doi. 10.1002/hon.3043
    By:
    • Takahashi, Hiromichi;
    • Miura, Katsuhiro;
    • Nakagawa, Masaru;
    • Nishimaki, Haruna;
    • Ito, Shun;
    • Nukariya, Hironao;
    • Kurihara, Kazuya;
    • Endo, Toshihide;
    • Koike, Takashi;
    • Hamada, Takashi;
    • Iizuka, Kazuhide;
    • Ohatake, Shimon;
    • Iriyama, Noriyoshi;
    • Nakayama, Tomohiro;
    • Masuda, Shinobu;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki
    Publication type:
    Article
    38
    39
    40
    41
    42

    Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2865, doi. 10.1007/s00262-023-03432-4
    By:
    • Naoe, Tomoki;
    • Saito, Akiko;
    • Hosono, Nahoko;
    • Kasahara, Senji;
    • Muto, Hideharu;
    • Hatano, Kaoru;
    • Ogura, Mizuki;
    • Masunari, Taro;
    • Tanaka, Masatsugu;
    • Usuki, Kensuke;
    • Ishikawa, Yuichi;
    • Ando, Koji;
    • Kondo, Yukio;
    • Takagi, Yusuke;
    • Takada, Satoru;
    • Ishikawa, Maho;
    • Choi, Ilseung;
    • Sano, Akihiro;
    • Nagai, Hirokazu
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50